INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 100 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $108,000 | -66.9% | 80,000 | -61.7% | 0.00% | -75.0% |
| Q3 2016 | $326,000 | +17.3% | 209,000 | 0.0% | 0.01% | +14.3% |
| Q2 2016 | $278,000 | -74.6% | 209,000 | 0.0% | 0.01% | -74.1% |
| Q1 2016 | $1,095,000 | -42.1% | 209,000 | -13.2% | 0.03% | -47.1% |
| Q4 2015 | $1,891,000 | -7.1% | 240,900 | 0.0% | 0.05% | +2.0% |
| Q3 2015 | $2,036,000 | -29.8% | 240,900 | -9.1% | 0.05% | -16.7% |
| Q2 2015 | $2,902,000 | -21.7% | 265,000 | 0.0% | 0.06% | -20.0% |
| Q1 2015 | $3,706,000 | -6.6% | 265,000 | +12.8% | 0.08% | -9.6% |
| Q4 2014 | $3,969,000 | – | 235,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 15,232,268 | $41,279,000 | 3.63% |
| NORTHPOINTE CAPITAL LLC | 528,739 | $1,433,000 | 0.21% |
| Opaleye Management Inc. | 275,000 | $745,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 364,401 | $988,000 | 0.12% |
| EcoR1 Capital, LLC | 462,068 | $1,252,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 990,748 | $2,685,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 284,354 | $771,000 | 0.04% |
| Fosun International Ltd | 358,859 | $879,000 | 0.04% |
| Clear Harbor Asset Management, LLC | 97,630 | $200,000 | 0.04% |
| 180 WEALTH ADVISORS, LLC | 30,000 | $81,000 | 0.04% |